| BGF EMERGING MARKETS EQUITY INCOME D2 USD | RVI EMERGENTES | 58,67% | 84,80% | 65,73% | 191,87% |
| BGF WORLD TECHNOLOGY D2 USD | RVI TECNOLOGÍA | 58,67% | 132,59% | 98,45% | 821,02% |
| ABRDN SICAV I-EMERGING MARKETS EQUITY FUND S ACC USD | RVI EMERGENTES | 58,66% | 68,45% | 25,66% | 90,32% |
| BNP PARIBAS EMERGING EQUITY CLASSIC EUR CAP | RVI EMERGENTES | 58,65% | 88,02% | 42,34% | 94,41% |
| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) USD | RVI BIOTECNOLOGÍA | 58,65% | 23,82% | -21,88% | · |
| SCHRODER ISF EMERGING MARKETS C DIS USD | RVI EMERGENTES | 58,65% | 76,01% | 34,46% | 129,35% |
| BGF WORLD GOLD E2 EUR | RVI MATERIAS PRIMAS | 58,63% | 160,73% | 132,81% | 126,22% |
| POLAR CAPITAL JAPAN VALUE R GBP DIS HEDGED | RVI JAPÓN VALOR | 58,62% | 131,95% | 202,17% | 414,06% |
| BARINGS ASIA GROWTH FUND A EUR INC | RVI ASIA EX-JAPÓN CRECIMIENTO | 58,61% | 78,11% | 24,31% | 181,49% |
| UBS (IRL) INVESTOR SELECTION - GLOBAL EMERGING MARKETS OPPORTUNITY (USD) I-A1-ACC | RVI EMERGENTES | 58,60% | 87,34% | 41,32% | 168,60% |
